http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10885033

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 142
issn 2577-171X
issueIdentifier 3
pageRange 139-142
publicationName IJU Case Reports
startingPage 139
bibliographicCitation Iwasaki K, Shin T, Inoue T, Shibuya T, Hirai K, Ando T, Mimata H. Only three cycles of nivolumab showed remarkable durable response and reversible myeloradiculoneuropathy in a patient with metastatic papillary renal cell carcinoma type 2. IJU Case Rep. 2021 May;4(3):139–42. PMID: 33977240; PMCID: PMC8088879.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7839-5861
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c22fbcd3f5f2967519b893554e44187a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f1be0ea6f69596a4dc2a3c219a4b686
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33f36f7f9f17f2597c48a6a9ae6c728c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd8647102df217908afd9f8c8cd81aba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4352f2a69a637dec57b367a62dc02b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30b26fe9d98d942d9fbcbeb207a61d7c
date 2021-02-17^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC8088879
https://doi.org/10.1002/iju5.12262
https://pubmed.ncbi.nlm.nih.gov/33977240
isPartOf https://portal.issn.org/resource/ISSN/2577-171X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/49421
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Only three cycles of nivolumab showed remarkable durable response and reversible myeloradiculoneuropathy in a patient with metastatic papillary renal cell carcinoma type 2
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10325

Showing number of triples: 1 to 28 of 28.